Cargando…

Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma

BACKGROUND: Circulating tumor cells (CTC) shows great prospect to realize precision medicine in cancer patients. METHODS: We developed the NanoVelcro Chip integrating three functional mechanisms. NanoVelcro CTC capture efficiency was tested in stage III or IV lung adenocarcinoma. Further, ALK-rearra...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Weiling, Xu, Di, Wang, Zhuo, Wu, Hui, Xiang, Xianhong, Tang, Bing, Jiang, Wenting, Cui, Yongmei, Wang, Han, Jiang, Neng, Sun, Yu, Chen, Yangshan, Li, Shuhua, Hou, Minzhi, Zhang, Yang, Wang, Liantang, Ke, Zun-fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339314/
https://www.ncbi.nlm.nih.gov/pubmed/30658713
http://dx.doi.org/10.1186/s12967-019-1779-5
_version_ 1783388609925087232
author He, Weiling
Xu, Di
Wang, Zhuo
Wu, Hui
Xiang, Xianhong
Tang, Bing
Jiang, Wenting
Cui, Yongmei
Wang, Han
Jiang, Neng
Sun, Yu
Chen, Yangshan
Li, Shuhua
Hou, Minzhi
Zhang, Yang
Wang, Liantang
Ke, Zun-fu
author_facet He, Weiling
Xu, Di
Wang, Zhuo
Wu, Hui
Xiang, Xianhong
Tang, Bing
Jiang, Wenting
Cui, Yongmei
Wang, Han
Jiang, Neng
Sun, Yu
Chen, Yangshan
Li, Shuhua
Hou, Minzhi
Zhang, Yang
Wang, Liantang
Ke, Zun-fu
author_sort He, Weiling
collection PubMed
description BACKGROUND: Circulating tumor cells (CTC) shows great prospect to realize precision medicine in cancer patients. METHODS: We developed the NanoVelcro Chip integrating three functional mechanisms. NanoVelcro CTC capture efficiency was tested in stage III or IV lung adenocarcinoma. Further, ALK-rearrangement status was examined through fluorescent in situ hybridization in CTCs enriched by NanoVelcro. RESULTS: NanoVelcro system showed higher CTC-capture efficiency than CellSearch in stage III or IV lung adenocarcinoma. CTC counts obtained by both methods were positively correlated (r = 0.45, p < 0.05). Further, Correlation between CTC counts and pTNM stage determined by NanoVelcro was more significant than that determined by CellSearch (p < 0.001 VS p = 0.029). All ALK-positive patients had 3 or more ALK-rearranged CTC per ml of blood. Less than 3 ALK-rearranged CTC was detected in ALK-negative patients. NanoVelcro can detect the ALK–rearranged status with consistent sensitivity and specificity compared to biopsy test. Furthermore, the ALK-rearranged CTC ratio correlated to the pTNM stage in ALK-positive patients. Following up showed that CTCs counting by NanoVelcro was more stable and reliable in evaluating the efficacy of Clozotinib both in the short and long run compared with CellSearch. Changing of NanoVlecro CTC counts could accurately reflect disease progression. CONCLUSION: NanoVelcro provides a sensitive method for CTC counts and characterization in advanced NSCLC. ALK-rearrangement can be detected in CTCs collected from advanced NSCLC patients by NanoVelcro, facilitating diagnostic test and prognosis analysis, most importantly offering one noninvasive method for real-time monitoring of treatment reaction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1779-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6339314
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63393142019-01-23 Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma He, Weiling Xu, Di Wang, Zhuo Wu, Hui Xiang, Xianhong Tang, Bing Jiang, Wenting Cui, Yongmei Wang, Han Jiang, Neng Sun, Yu Chen, Yangshan Li, Shuhua Hou, Minzhi Zhang, Yang Wang, Liantang Ke, Zun-fu J Transl Med Research BACKGROUND: Circulating tumor cells (CTC) shows great prospect to realize precision medicine in cancer patients. METHODS: We developed the NanoVelcro Chip integrating three functional mechanisms. NanoVelcro CTC capture efficiency was tested in stage III or IV lung adenocarcinoma. Further, ALK-rearrangement status was examined through fluorescent in situ hybridization in CTCs enriched by NanoVelcro. RESULTS: NanoVelcro system showed higher CTC-capture efficiency than CellSearch in stage III or IV lung adenocarcinoma. CTC counts obtained by both methods were positively correlated (r = 0.45, p < 0.05). Further, Correlation between CTC counts and pTNM stage determined by NanoVelcro was more significant than that determined by CellSearch (p < 0.001 VS p = 0.029). All ALK-positive patients had 3 or more ALK-rearranged CTC per ml of blood. Less than 3 ALK-rearranged CTC was detected in ALK-negative patients. NanoVelcro can detect the ALK–rearranged status with consistent sensitivity and specificity compared to biopsy test. Furthermore, the ALK-rearranged CTC ratio correlated to the pTNM stage in ALK-positive patients. Following up showed that CTCs counting by NanoVelcro was more stable and reliable in evaluating the efficacy of Clozotinib both in the short and long run compared with CellSearch. Changing of NanoVlecro CTC counts could accurately reflect disease progression. CONCLUSION: NanoVelcro provides a sensitive method for CTC counts and characterization in advanced NSCLC. ALK-rearrangement can be detected in CTCs collected from advanced NSCLC patients by NanoVelcro, facilitating diagnostic test and prognosis analysis, most importantly offering one noninvasive method for real-time monitoring of treatment reaction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1779-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-18 /pmc/articles/PMC6339314/ /pubmed/30658713 http://dx.doi.org/10.1186/s12967-019-1779-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
He, Weiling
Xu, Di
Wang, Zhuo
Wu, Hui
Xiang, Xianhong
Tang, Bing
Jiang, Wenting
Cui, Yongmei
Wang, Han
Jiang, Neng
Sun, Yu
Chen, Yangshan
Li, Shuhua
Hou, Minzhi
Zhang, Yang
Wang, Liantang
Ke, Zun-fu
Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma
title Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma
title_full Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma
title_fullStr Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma
title_full_unstemmed Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma
title_short Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma
title_sort three-dimensional nanostructured substrates enable dynamic detection of alk-rearrangement in circulating tumor cells from treatment-naive patients with stage iii/iv lung adenocarcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339314/
https://www.ncbi.nlm.nih.gov/pubmed/30658713
http://dx.doi.org/10.1186/s12967-019-1779-5
work_keys_str_mv AT heweiling threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT xudi threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT wangzhuo threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT wuhui threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT xiangxianhong threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT tangbing threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT jiangwenting threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT cuiyongmei threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT wanghan threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT jiangneng threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT sunyu threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT chenyangshan threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT lishuhua threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT houminzhi threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT zhangyang threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT wangliantang threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma
AT kezunfu threedimensionalnanostructuredsubstratesenabledynamicdetectionofalkrearrangementincirculatingtumorcellsfromtreatmentnaivepatientswithstageiiiivlungadenocarcinoma